These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8623850)

  • 1. Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.
    Guzick DS; Talbott EO; Sutton-Tyrrell K; Herzog HC; Kuller LH; Wolfson SK
    Am J Obstet Gynecol; 1996 Apr; 174(4):1224-9; discussion 1229-32. PubMed ID: 8623850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women.
    Talbott EO; Guzick DS; Sutton-Tyrrell K; McHugh-Pemu KP; Zborowski JV; Remsberg KE; Kuller LH
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2414-21. PubMed ID: 11073846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome.
    Adali E; Yildizhan R; Kurdoglu M; Bugdayci G; Kolusari A; Sahin HG
    Fertil Steril; 2010 Jul; 94(2):666-72. PubMed ID: 19368913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.
    Zueff LF; Martins WP; Vieira CS; Ferriani RA
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):341-7. PubMed ID: 21898634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome.
    Vryonidou A; Papatheodorou A; Tavridou A; Terzi T; Loi V; Vatalas IA; Batakis N; Phenekos C; Dionyssiou-Asteriou A
    J Clin Endocrinol Metab; 2005 May; 90(5):2740-6. PubMed ID: 15741256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome.
    Tripathy P; Sahu A; Sahu M; Nagy A
    Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():18-22. PubMed ID: 28850821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.
    Legro RS; Kunselman AR; Dunaif A
    Am J Med; 2001 Dec; 111(8):607-13. PubMed ID: 11755503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype.
    Lerchbaum E; Schwetz V; Rabe T; Giuliani A; Obermayer-Pietsch B
    PLoS One; 2014; 9(10):e108263. PubMed ID: 25310562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism.
    Pei YJ; Wang AM; Zhao Y; Yan L; Li M; White RE; Han GC
    Gynecol Endocrinol; 2014 Aug; 30(8):553-6. PubMed ID: 24884959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperinsulinemia and carotid atherosclerosis in hypertensive and control subjects.
    Rantala AO; Päivänsalo M; Kauma H; Lilja M; Savolainen MJ; Reunanen A; Kesäniemi YA
    Diabetes Care; 1998 Jul; 21(7):1188-93. PubMed ID: 9653618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.
    Arikan S; Akay H; Bahceci M; Tuzcu A; Gokalp D
    Fertil Steril; 2009 Feb; 91(2):450-5. PubMed ID: 18501898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
    Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.
    Vieira CS; Martins WP; Fernandes JB; Soares GM; dos Reis RM; de Sá MF; Ferriani RA
    Contraception; 2012 Sep; 86(3):268-75. PubMed ID: 22464410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome.
    Talbott EO; Zborowski JV; Boudreaux MY; McHugh-Pemu KP; Sutton-Tyrrell K; Guzick DS
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6061-7. PubMed ID: 15579759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonographic extended-view technique for evaluation of abdominal fat distribution in lean women with polycystic ovary syndrome.
    Battaglia C; Battaglia B; Mancini F; Paradisi R; Fabbri R; Venturoli S
    Acta Obstet Gynecol Scand; 2011 Jun; 90(6):600-8. PubMed ID: 21401530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does cardiovascular risk vary according to the criteria for a diagnosis of polycystic ovary syndrome?
    Ramoglu S; Yoldemir T; Atasayan K; Yavuz DG
    J Obstet Gynaecol Res; 2017 Dec; 43(12):1848-1854. PubMed ID: 28892255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma thiols and androgen levels in polycystic ovary syndrome.
    Vrbíková J; Tallová J; Biciková M; Dvoráková K; Hill M; Stárka L
    Clin Chem Lab Med; 2003 Feb; 41(2):216-21. PubMed ID: 12667010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.